Distribution of Z-Scores in a university cohort with an emphasis on "high" bone mineral density

Journal of Clinical Densitometry

Volumn 13, Issue 4, 2010, Pages 385-391

  Morgan, Sarah L ^a   Peace, Frederick ^a   Lopez Ben, Robert ^a,b   Fineberg, Naomi ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Dual energy X ray absorptiometry; High bone mineral density; Z score

Indexed keywords

GLUCOCORTICOID; HORMONE;

ADULT; ARTICLE; ASTHMA; BODY MASS; BONE DENSITY; CONTROLLED STUDY; CYSTIC FIBROSIS; DATA BASE; DUAL ENERGY X RAY ABSORPTIOMETRY; EATING DISORDER; FEMALE; FEMUR NECK; FRACTURE; HEIGHT; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUMBAR SPINE; LUPUS VULGARIS; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SMOKING; UNIVERSITY; WEIGHT;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BONE DENSITY; COHORT STUDIES; COMORBIDITY; FEMALE; FEMUR NECK; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SPINE; UNIVERSITIES;

EID: 77958492016     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocd.2010.07.003     Document Type: Article

References (30)

1. National Osteoporosis Foundation Clinician's guide to prevention and treatment of osteoporosis 2008, National Osteoporosis Foundation, Washington, DC.
2. World Health Organization Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series 843 1994, World Health Organization, Geneva, Switzerland.
3. Whyte M.P. Chapter 88. Sclerosing bone disorders. Primer on the metabolic bone diseases and disorders of mineral metabolism 2008, 412-423. American Society for Bone and Mineral Research, Washington, DC. C.J. Rosen (Ed.).
4. Simonelli C., Adler R.A., Blake G.M., et al. Dual-energy x-ray absorptiometry technical issues: the 2007 ISCD Official Positions. J Clin Densitom 2008, 11:109-122.
5. Whyte M.P. Misinterpretation of osteodensitometry with high bone density: BMD Z ≥+2.5 is not " normal" J Clin Densitom 2005, 8:1-6.
6. Brown J.P., Josse R.G. Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can Med Assoc J 2002, 167(10 Suppl):S1-S34.
7. Grynpas M. Age and disease-related changes in the mineral of bone. Calcif Tissue Int 1993, 53:S57-S64.
8. Yamauchi T., Taketomi E., Matsunaga S., Sakou T. Bone mineral density in patients with ossification of the posterior longitudinal ligament in the cervical spine. J Bone Miner Metab 1999, 17:296-300.
9. Westerveld L.A., Verlaan J.J., Lam M.G., et al. The influence of diffuse idiopathic skeletal hyperostosis on bone mineral density measurements of the spine. Rheumatology (Oxford) 2009, 48:1133-1136.
10. Schwartz J.B., Rackson M. Diffuse idiopathic skeletal hyperostosis causes artificially elevated lumbar bone mineral density measured by dual x-ray absorptiometry. J Clin Densitom 2001, 4:385-388.
11. Yu W., Gluer C.C., Fuerst T., et al. Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women. Calcif Tissue Int 1995, 57:169-174.
12. Whyte M.P., Totty W.G., Lim V.T., Whitford G.M. Case report. Skeletal fluorosis from instant tea. J Bone Miner Res 2008, 23:759-769.
13. Kurland E.S., Schulman R.C., Zerwekh J.E., et al. Recovery from skeletal fluorosis (an enigmatic American case). J Bone Miner Res 2007, 22:163-170.
14. Whyte M.P., Essmyer K., Gannon F.H., Reinus W.R. Skeletal fluorosis and instant tea. Am J Med 2005, 118:78-82.
15. Hallanger Johnson J.E., Kearns A.E., Doran P.M., et al. Fluoride-related bone disease associated with habitual tea consumption. Mayo Clin Proc 2007, 82:719-724.
16. El-Khoury G.Y., Moore T.E., Albright J.P., et al. Sodium fluoride treatment of osteoporosis: radiologic findings. Am J Roentgenol 1982, 139:39-43.
17. Whyte M.P., McAlister W.H., Novack D.V., et al. Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases. J Bone Miner Res 2008, 23:1698-1707.
18. Whyte M.P., Wenkert D., Clements K.L., et al. Bisphosphonate-induced osteopetrosis. N Engl J Med 2003, 349:457-463.
19. Blake G.M., Fogelman I. The correction of BMD measurement for bone strontium content. J Clin Densitom 2007, 10:259-265.
20. Adachi J., Ioannidis G. Primer on corticosteroid-induced osteoporosis 2000, Lippincott-Williams & Wilkins, Philadelphia, PA.
21. Nelson R.L., Turky M., Kim J., et al. Bone mineral density and subsequent risk of prostate cancer in the NHANES I follow-up. IARC Sci Publ 2002, 156:319-321.
22. Nelson R.L., Turyk M., Kim J., et al. Bone mineral density and the subsequent risk of prostate cancer in the NHANES I follow-up cohort. BMC Cancer 2002, 2:22.
23. Boyanov M., Bakalov D., Boneva Z. Bone mineral density in men with and without the metabolic syndrome. Aging Male 2009, 24:1-4.
24. Kelly T.L. Bone mineral reference databases for American men and women. J Bone Miner Res 1990, 5:249.
25. Kanis J.A., McCloskey E.V., Johansson H., et al. A reference standard for the description of osteoporosis. Bone 2008, 42:467-475.
26. Chen Z., Maricic M., Lund P., et al. How the new Hologic hip normal reference values affect the densitometric diagnosis of osteoporosis. Osteoporos Int 1998, 8:423-427.
27. Kiebzak G.M., Binkley N., Lewiecki E.M., Miller P.D. Diagnostic agreement at the total hip using different DXA systems and the NHANES III database. J Clin Densitom 2007, 10:132-137.
28. Binkley N., Kiebzak G.M., Lewiecki E.M., et al. Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence. J Bone Miner Res 2005, 20:195-210.
29. Vallarta-Ast N., Wrase C., Krueger D., Binkley N. High BMD: how common is it?. J Clin Densitom 2008, 11:455.
30. Kanis J.A., Melton L.J., Christiansen C., et al. The diagnosis of osteoporosis. J Bone Miner Res 1994, 9:1137-1141.